spacer
home > > spring 2002 > stem cells - the clinician's 'philosopher's stone'
PUBLICATIONS


Stem Cells - The Clinician's 'Philosopher's Stone'

2001 saw an explosion of interest in stem cells, both in scientific literature and the popular press. Much of this revolved around emotive issues related to manipulation of the pluripotentiality (ability to produce many cell types) of either embryonic or adult stem cells. However, there is still a poor appreciation among the commercial scientific community of the importance of adult tissue stem cells in normal tissue homeostasis and how drugs affect their behaviour. A thorough preclinical evaluation of the effects of potential new drugs on these adult tissue stem cells can reveal mechanisms of action that can significantly improve the efficacy of clinical trials and reduce late stage drug failure.

The Definition and Importance of Stem Cells in Tissue Homeostasis

The fertilised zygote is the ultimate totipotential (capable of making all cell types) stem cell, capable of forming all the differentiated cells and tissues of the body according to strict temporal and spatial controls. The factors that regulate these processes during development are only beginning to be understood. The early divisions of the zygote during development produce further totipotent stem cells and - at least up to the blastocyst stage - cells of the inner cell mass can be isolated, grown and expanded in culture as embryonic stem (ES) cells.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Professor Christopher Potten, Founder of EpiStem Ltd

Professor Christopher Potten is an Emeritus Professor of the UK Cancer Research Campaign, Professor of Stem Cell Biology at Manchester University and a Founder of EpiStem Ltd, a specialist preclinical CRO.

He is a world expert in epithelial stem cell biology and apoptosis, publishing around 400 papers in these areas, and over recent years has assisted many pharmaceutical companies in evaluating their novel anti-cancer and mucositis therapies.

spacer
Professor Christopher Potten
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement